FDA draft guidance would let one license cover many patient-specific gene-editing variants
New variants within a defined feature space could be added after approval without new trials; comments are due November 27.
- Nasdaq slides 2.9% as Intel has its worst day since the 1970s and chip stocks fall
- Apple says Apple Intelligence features will reach China with iOS 27.3, using Alibaba's Qwen in Siri and Writing Tools
- Intel shares fall 29%, their worst day since the 1970s, cutting about $12 billion from the US government's stake
- Mistral releases open weights for Mistral Large 4, its 1-trillion-parameter model
- S&P revises Meta's outlook to negative over AI capital spending and negative free cash flow
- Google's Suncatcher satellite returns the first AI response from a data-centre TPU in orbit
- Five tech giants hold more than $3 trillion in future AI spending commitments, Bloomberg tally finds
- Anthropic renames Claude Max 20x to Ultra and drops the 5-hour limit for verified Ultra accounts